nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Sorafenib—liver cancer	0.181	0.457	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—liver cancer	0.11	0.277	CbGbCtD
Sumatriptan—ABCB1—Sorafenib—liver cancer	0.0651	0.165	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—liver cancer	0.0395	0.1	CbGbCtD
Sumatriptan—Almotriptan—CYP2E1—liver cancer	0.00226	0.4	CrCbGaD
Sumatriptan—Melatonin—ESR1—liver cancer	0.00188	0.333	CrCbGaD
Sumatriptan—Melatonin—CYP1A1—liver cancer	0.00151	0.267	CrCbGaD
Sumatriptan—Dermatitis contact—Doxorubicin—liver cancer	0.000894	0.0019	CcSEcCtD
Sumatriptan—Eructation—Doxorubicin—liver cancer	0.000889	0.00188	CcSEcCtD
Sumatriptan—Bladder pain—Epirubicin—liver cancer	0.000884	0.00187	CcSEcCtD
Sumatriptan—Cystitis noninfective—Doxorubicin—liver cancer	0.000884	0.00187	CcSEcCtD
Sumatriptan—Melaena—Doxorubicin—liver cancer	0.000884	0.00187	CcSEcCtD
Sumatriptan—Salivary hypersecretion—Doxorubicin—liver cancer	0.000879	0.00186	CcSEcCtD
Sumatriptan—Cystitis—Doxorubicin—liver cancer	0.000873	0.00185	CcSEcCtD
Sumatriptan—Colitis—Doxorubicin—liver cancer	0.000869	0.00184	CcSEcCtD
Sumatriptan—Skin exfoliation—Doxorubicin—liver cancer	0.000864	0.00183	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00086	0.00182	CcSEcCtD
Sumatriptan—Fluid retention—Doxorubicin—liver cancer	0.000859	0.00182	CcSEcCtD
Sumatriptan—Dyspnoea—Sorafenib—liver cancer	0.000841	0.00178	CcSEcCtD
Sumatriptan—Lymphadenopathy—Epirubicin—liver cancer	0.000832	0.00176	CcSEcCtD
Sumatriptan—Phlebitis—Epirubicin—liver cancer	0.000824	0.00175	CcSEcCtD
Sumatriptan—Decreased appetite—Sorafenib—liver cancer	0.00082	0.00174	CcSEcCtD
Sumatriptan—Thrombophlebitis—Epirubicin—liver cancer	0.00082	0.00174	CcSEcCtD
Sumatriptan—Bladder pain—Doxorubicin—liver cancer	0.000818	0.00173	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Sorafenib—liver cancer	0.000815	0.00173	CcSEcCtD
Sumatriptan—Fatigue—Sorafenib—liver cancer	0.000814	0.00173	CcSEcCtD
Sumatriptan—Photosensitivity—Epirubicin—liver cancer	0.000808	0.00171	CcSEcCtD
Sumatriptan—Pain—Sorafenib—liver cancer	0.000807	0.00171	CcSEcCtD
Sumatriptan—Constipation—Sorafenib—liver cancer	0.000807	0.00171	CcSEcCtD
Sumatriptan—Eczema—Epirubicin—liver cancer	0.00079	0.00167	CcSEcCtD
Sumatriptan—Eye pain—Epirubicin—liver cancer	0.000786	0.00167	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Sorafenib—liver cancer	0.000772	0.00164	CcSEcCtD
Sumatriptan—Lymphadenopathy—Doxorubicin—liver cancer	0.00077	0.00163	CcSEcCtD
Sumatriptan—Renal failure acute—Epirubicin—liver cancer	0.000769	0.00163	CcSEcCtD
Sumatriptan—Phlebitis—Doxorubicin—liver cancer	0.000762	0.00162	CcSEcCtD
Sumatriptan—Thrombophlebitis—Doxorubicin—liver cancer	0.000759	0.00161	CcSEcCtD
Sumatriptan—Urticaria—Sorafenib—liver cancer	0.00075	0.00159	CcSEcCtD
Sumatriptan—Photosensitivity—Doxorubicin—liver cancer	0.000748	0.00159	CcSEcCtD
Sumatriptan—Abdominal pain—Sorafenib—liver cancer	0.000746	0.00158	CcSEcCtD
Sumatriptan—Body temperature increased—Sorafenib—liver cancer	0.000746	0.00158	CcSEcCtD
Sumatriptan—Dermatitis bullous—Epirubicin—liver cancer	0.000743	0.00157	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Epirubicin—liver cancer	0.000733	0.00155	CcSEcCtD
Sumatriptan—Eczema—Doxorubicin—liver cancer	0.000731	0.00155	CcSEcCtD
Sumatriptan—Eye pain—Doxorubicin—liver cancer	0.000727	0.00154	CcSEcCtD
Sumatriptan—Hypoglycaemia—Epirubicin—liver cancer	0.000727	0.00154	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Epirubicin—liver cancer	0.000724	0.00154	CcSEcCtD
Sumatriptan—Renal failure acute—Doxorubicin—liver cancer	0.000711	0.00151	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00071	0.0015	CcSEcCtD
Sumatriptan—Diplopia—Epirubicin—liver cancer	0.00071	0.0015	CcSEcCtD
Sumatriptan—Osteoarthritis—Epirubicin—liver cancer	0.00071	0.0015	CcSEcCtD
Sumatriptan—Migraine—Epirubicin—liver cancer	0.000699	0.00148	CcSEcCtD
Sumatriptan—Hypersensitivity—Sorafenib—liver cancer	0.000695	0.00147	CcSEcCtD
Sumatriptan—Dermatitis bullous—Doxorubicin—liver cancer	0.000687	0.00146	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000678	0.00144	CcSEcCtD
Sumatriptan—Asthenia—Sorafenib—liver cancer	0.000677	0.00144	CcSEcCtD
Sumatriptan—Hypoglycaemia—Doxorubicin—liver cancer	0.000673	0.00143	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Doxorubicin—liver cancer	0.00067	0.00142	CcSEcCtD
Sumatriptan—Pruritus—Sorafenib—liver cancer	0.000668	0.00142	CcSEcCtD
Sumatriptan—Dehydration—Epirubicin—liver cancer	0.00066	0.0014	CcSEcCtD
Sumatriptan—Osteoarthritis—Doxorubicin—liver cancer	0.000657	0.00139	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000657	0.00139	CcSEcCtD
Sumatriptan—Diplopia—Doxorubicin—liver cancer	0.000657	0.00139	CcSEcCtD
Sumatriptan—Liver function test abnormal—Epirubicin—liver cancer	0.000655	0.00139	CcSEcCtD
Sumatriptan—Migraine—Doxorubicin—liver cancer	0.000646	0.00137	CcSEcCtD
Sumatriptan—Diarrhoea—Sorafenib—liver cancer	0.000646	0.00137	CcSEcCtD
Sumatriptan—Gastritis—Epirubicin—liver cancer	0.000628	0.00133	CcSEcCtD
Sumatriptan—Dizziness—Sorafenib—liver cancer	0.000624	0.00132	CcSEcCtD
Sumatriptan—Abdominal distension—Epirubicin—liver cancer	0.000617	0.00131	CcSEcCtD
Sumatriptan—Asthma—Epirubicin—liver cancer	0.000613	0.0013	CcSEcCtD
Sumatriptan—Dysphagia—Epirubicin—liver cancer	0.000613	0.0013	CcSEcCtD
Sumatriptan—Influenza—Epirubicin—liver cancer	0.000613	0.0013	CcSEcCtD
Sumatriptan—Dehydration—Doxorubicin—liver cancer	0.000611	0.00129	CcSEcCtD
Sumatriptan—Liver function test abnormal—Doxorubicin—liver cancer	0.000606	0.00129	CcSEcCtD
Sumatriptan—Pancreatitis—Epirubicin—liver cancer	0.000601	0.00128	CcSEcCtD
Sumatriptan—Vomiting—Sorafenib—liver cancer	0.0006	0.00127	CcSEcCtD
Sumatriptan—Angina pectoris—Epirubicin—liver cancer	0.000597	0.00127	CcSEcCtD
Sumatriptan—Rash—Sorafenib—liver cancer	0.000595	0.00126	CcSEcCtD
Sumatriptan—Dermatitis—Sorafenib—liver cancer	0.000595	0.00126	CcSEcCtD
Sumatriptan—Headache—Sorafenib—liver cancer	0.000591	0.00125	CcSEcCtD
Sumatriptan—Bronchitis—Epirubicin—liver cancer	0.00059	0.00125	CcSEcCtD
Sumatriptan—Pancytopenia—Epirubicin—liver cancer	0.000583	0.00124	CcSEcCtD
Sumatriptan—Gastritis—Doxorubicin—liver cancer	0.000581	0.00123	CcSEcCtD
Sumatriptan—Dysuria—Epirubicin—liver cancer	0.000574	0.00122	CcSEcCtD
Sumatriptan—Abdominal distension—Doxorubicin—liver cancer	0.000571	0.00121	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—liver cancer	0.000568	0.0012	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—liver cancer	0.000568	0.0012	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—liver cancer	0.000568	0.0012	CcSEcCtD
Sumatriptan—Pollakiuria—Epirubicin—liver cancer	0.000567	0.0012	CcSEcCtD
Sumatriptan—Nausea—Sorafenib—liver cancer	0.000561	0.00119	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Epirubicin—liver cancer	0.00056	0.00119	CcSEcCtD
Sumatriptan—Weight increased—Epirubicin—liver cancer	0.000558	0.00118	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—liver cancer	0.000556	0.00118	CcSEcCtD
Sumatriptan—Weight decreased—Epirubicin—liver cancer	0.000555	0.00118	CcSEcCtD
Sumatriptan—Hyperglycaemia—Epirubicin—liver cancer	0.000553	0.00117	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—liver cancer	0.000553	0.00117	CcSEcCtD
Sumatriptan—Drowsiness—Epirubicin—liver cancer	0.000547	0.00116	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—liver cancer	0.000546	0.00116	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—liver cancer	0.000539	0.00114	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—liver cancer	0.000532	0.00113	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—liver cancer	0.000531	0.00113	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—liver cancer	0.000524	0.00111	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—liver cancer	0.000524	0.00111	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—liver cancer	0.000521	0.00111	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—liver cancer	0.000518	0.0011	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—liver cancer	0.000516	0.0011	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—liver cancer	0.000516	0.00109	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—liver cancer	0.000513	0.00109	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—liver cancer	0.000513	0.00109	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—liver cancer	0.000512	0.00109	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—liver cancer	0.000506	0.00107	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—liver cancer	0.0005	0.00106	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—liver cancer	0.000493	0.00105	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—liver cancer	0.000492	0.00104	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—liver cancer	0.000491	0.00104	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—liver cancer	0.000488	0.00104	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—liver cancer	0.000485	0.00103	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—liver cancer	0.000482	0.00102	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—liver cancer	0.000482	0.00102	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—liver cancer	0.000477	0.00101	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—liver cancer	0.000475	0.00101	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—liver cancer	0.000473	0.001	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—liver cancer	0.000462	0.000981	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—liver cancer	0.000459	0.000973	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—liver cancer	0.000458	0.000971	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—liver cancer	0.000457	0.000968	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—liver cancer	0.000456	0.000966	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—liver cancer	0.000454	0.000963	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—liver cancer	0.000452	0.000958	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—liver cancer	0.000446	0.000947	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—liver cancer	0.000445	0.000944	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—liver cancer	0.000443	0.00094	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—liver cancer	0.000442	0.000938	CcSEcCtD
Sumatriptan—Chills—Epirubicin—liver cancer	0.000441	0.000934	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—liver cancer	0.000439	0.00093	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—liver cancer	0.000438	0.000928	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—liver cancer	0.000427	0.000906	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—liver cancer	0.000425	0.0009	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—liver cancer	0.000424	0.000898	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—liver cancer	0.000422	0.000894	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—liver cancer	0.000421	0.000893	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—liver cancer	0.000419	0.000887	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—liver cancer	0.000413	0.000877	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—liver cancer	0.000412	0.000874	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—liver cancer	0.000411	0.000871	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—liver cancer	0.00041	0.00087	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—liver cancer	0.000409	0.000868	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—liver cancer	0.000408	0.000864	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—liver cancer	0.000406	0.00086	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—liver cancer	0.000397	0.000841	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—liver cancer	0.000395	0.000838	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—liver cancer	0.000395	0.000838	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—liver cancer	0.000393	0.000833	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—liver cancer	0.00039	0.000826	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—liver cancer	0.000387	0.000821	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—liver cancer	0.000385	0.000817	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—liver cancer	0.000384	0.000814	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—liver cancer	0.000383	0.000813	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—liver cancer	0.000383	0.000811	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—liver cancer	0.00038	0.000806	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—liver cancer	0.000378	0.000801	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—liver cancer	0.000376	0.000796	CcSEcCtD
Sumatriptan—Cough—Epirubicin—liver cancer	0.000373	0.000791	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—liver cancer	0.00037	0.000785	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—liver cancer	0.000369	0.000782	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—liver cancer	0.000367	0.000778	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—liver cancer	0.000365	0.000775	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—liver cancer	0.000364	0.000771	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—liver cancer	0.000364	0.000771	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—liver cancer	0.000364	0.000771	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—liver cancer	0.000363	0.000771	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—liver cancer	0.000363	0.000769	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—liver cancer	0.000359	0.000762	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—liver cancer	0.000357	0.000756	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—liver cancer	0.000356	0.000755	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—liver cancer	0.000355	0.000753	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—liver cancer	0.000355	0.000752	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—liver cancer	0.000352	0.000746	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—liver cancer	0.000349	0.000741	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—liver cancer	0.000349	0.00074	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—liver cancer	0.000349	0.00074	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—liver cancer	0.000348	0.000737	CcSEcCtD
Sumatriptan—Infection—Epirubicin—liver cancer	0.000347	0.000735	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—liver cancer	0.000345	0.000732	CcSEcCtD
Sumatriptan—Shock—Epirubicin—liver cancer	0.000343	0.000728	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—liver cancer	0.000343	0.000726	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—liver cancer	0.000342	0.000725	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—liver cancer	0.000342	0.000724	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—liver cancer	0.000341	0.000724	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—liver cancer	0.00034	0.000722	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—liver cancer	0.000339	0.000718	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—liver cancer	0.000337	0.000715	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—liver cancer	0.000337	0.000714	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—liver cancer	0.000337	0.000714	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—liver cancer	0.000337	0.000714	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—liver cancer	0.000336	0.000711	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—liver cancer	0.000333	0.000705	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—liver cancer	0.000329	0.000698	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—liver cancer	0.000326	0.000691	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—liver cancer	0.000325	0.00069	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—liver cancer	0.000323	0.000684	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—liver cancer	0.000323	0.000684	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—liver cancer	0.000321	0.00068	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000318	0.000674	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—liver cancer	0.000318	0.000673	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—liver cancer	0.000317	0.000671	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—liver cancer	0.000316	0.00067	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—liver cancer	0.000315	0.000668	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—liver cancer	0.000313	0.000665	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—liver cancer	0.000313	0.000664	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—liver cancer	0.000312	0.000662	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—liver cancer	0.000311	0.000659	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—liver cancer	0.00031	0.000657	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—liver cancer	0.000303	0.000643	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—liver cancer	0.000302	0.000639	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—liver cancer	0.000301	0.000638	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—liver cancer	0.000301	0.000638	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—liver cancer	0.000298	0.000632	CcSEcCtD
Sumatriptan—Pain—Epirubicin—liver cancer	0.000298	0.000632	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000294	0.000623	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—liver cancer	0.00029	0.000614	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—liver cancer	0.000288	0.00061	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—liver cancer	0.000287	0.000609	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—liver cancer	0.000287	0.000608	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—liver cancer	0.000285	0.000605	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—liver cancer	0.000281	0.000595	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000279	0.000591	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—liver cancer	0.000278	0.00059	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—liver cancer	0.000277	0.000588	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—liver cancer	0.000276	0.000585	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—liver cancer	0.000276	0.000585	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—liver cancer	0.000276	0.000585	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—liver cancer	0.000276	0.000585	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—liver cancer	0.000266	0.000564	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—liver cancer	0.000264	0.00056	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—liver cancer	0.000257	0.000545	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—liver cancer	0.000256	0.000544	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—liver cancer	0.000255	0.000541	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—liver cancer	0.000255	0.000541	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—liver cancer	0.00025	0.000531	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—liver cancer	0.000247	0.000523	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—liver cancer	0.000239	0.000506	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—liver cancer	0.000238	0.000504	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—liver cancer	0.000232	0.000491	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—liver cancer	0.000231	0.000489	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—liver cancer	0.000228	0.000484	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—liver cancer	0.000222	0.00047	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—liver cancer	0.000221	0.000468	CcSEcCtD
Sumatriptan—Rash—Epirubicin—liver cancer	0.00022	0.000466	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—liver cancer	0.00022	0.000466	CcSEcCtD
Sumatriptan—Headache—Epirubicin—liver cancer	0.000219	0.000463	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—liver cancer	0.000213	0.000453	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—liver cancer	0.000207	0.000439	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—liver cancer	0.000205	0.000435	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—liver cancer	0.000203	0.000431	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—liver cancer	0.000203	0.000431	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—liver cancer	0.000202	0.000429	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—liver cancer	0.000192	0.000406	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—AKT1—liver cancer	3.1e-05	0.000243	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CD—liver cancer	3.09e-05	0.000242	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CG—liver cancer	3.09e-05	0.000242	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—liver cancer	3.07e-05	0.00024	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—liver cancer	3.07e-05	0.00024	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—liver cancer	3.05e-05	0.000239	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—liver cancer	3.05e-05	0.000238	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KDR—liver cancer	3.02e-05	0.000237	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK14—liver cancer	3e-05	0.000235	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	2.99e-05	0.000234	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—liver cancer	2.99e-05	0.000234	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JUN—liver cancer	2.98e-05	0.000234	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—liver cancer	2.97e-05	0.000233	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CB—liver cancer	2.97e-05	0.000232	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—liver cancer	2.96e-05	0.000232	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KDR—liver cancer	2.96e-05	0.000232	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CTNNB1—liver cancer	2.96e-05	0.000232	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ESR1—liver cancer	2.95e-05	0.000231	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HPGDS—liver cancer	2.94e-05	0.000231	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK14—liver cancer	2.94e-05	0.00023	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CG—liver cancer	2.92e-05	0.000229	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARA—liver cancer	2.92e-05	0.000228	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—F2—liver cancer	2.91e-05	0.000228	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—liver cancer	2.9e-05	0.000227	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1A—liver cancer	2.89e-05	0.000226	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ESR1—liver cancer	2.89e-05	0.000226	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—F2—liver cancer	2.85e-05	0.000223	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.83e-05	0.000222	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK8—liver cancer	2.82e-05	0.000221	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—liver cancer	2.82e-05	0.000221	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—liver cancer	2.81e-05	0.00022	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CG—liver cancer	2.79e-05	0.000218	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APC—liver cancer	2.79e-05	0.000218	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CD—liver cancer	2.77e-05	0.000217	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.77e-05	0.000217	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CSF2—liver cancer	2.77e-05	0.000217	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RAF1—liver cancer	2.76e-05	0.000216	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCE—liver cancer	2.75e-05	0.000215	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—liver cancer	2.74e-05	0.000214	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CG—liver cancer	2.73e-05	0.000214	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APC—liver cancer	2.73e-05	0.000214	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—H2AFX—liver cancer	2.73e-05	0.000214	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—liver cancer	2.73e-05	0.000213	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CD—liver cancer	2.72e-05	0.000213	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CG—liver cancer	2.7e-05	0.000211	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CB—liver cancer	2.7e-05	0.000211	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMA4—liver cancer	2.62e-05	0.000205	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PSMD10—liver cancer	2.62e-05	0.000205	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—liver cancer	2.62e-05	0.000205	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	2.61e-05	0.000204	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—VEGFA—liver cancer	2.61e-05	0.000204	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—liver cancer	2.6e-05	0.000204	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—liver cancer	2.6e-05	0.000204	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—liver cancer	2.58e-05	0.000202	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CD—liver cancer	2.57e-05	0.000201	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—liver cancer	2.56e-05	0.000201	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT2—liver cancer	2.55e-05	0.0002	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—liver cancer	2.54e-05	0.000199	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.5e-05	0.000196	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—liver cancer	2.5e-05	0.000196	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—liver cancer	2.48e-05	0.000194	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—liver cancer	2.47e-05	0.000193	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CD—liver cancer	2.45e-05	0.000192	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CSF2—liver cancer	2.43e-05	0.00019	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—liver cancer	2.43e-05	0.00019	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAF1—liver cancer	2.42e-05	0.00019	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SERPINE1—liver cancer	2.42e-05	0.00019	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—liver cancer	2.42e-05	0.000189	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—liver cancer	2.41e-05	0.000189	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—liver cancer	2.4e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—liver cancer	2.4e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—liver cancer	2.4e-05	0.000188	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—liver cancer	2.4e-05	0.000188	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—H2AFX—liver cancer	2.39e-05	0.000187	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—liver cancer	2.39e-05	0.000187	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFB1—liver cancer	2.39e-05	0.000187	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—liver cancer	2.38e-05	0.000186	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SERPINE1—liver cancer	2.37e-05	0.000186	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—liver cancer	2.37e-05	0.000186	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—liver cancer	2.37e-05	0.000185	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—liver cancer	2.35e-05	0.000184	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—liver cancer	2.34e-05	0.000183	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.26e-05	0.000177	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—liver cancer	2.26e-05	0.000177	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYCS—liver cancer	2.25e-05	0.000176	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK14—liver cancer	2.24e-05	0.000175	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—liver cancer	2.24e-05	0.000175	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—liver cancer	2.22e-05	0.000173	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GGT1—liver cancer	2.2e-05	0.000173	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GOT1—liver cancer	2.2e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—liver cancer	2.2e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—liver cancer	2.2e-05	0.000172	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—liver cancer	2.2e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAF1—liver cancer	2.19e-05	0.000171	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—liver cancer	2.17e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—F2—liver cancer	2.17e-05	0.00017	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—liver cancer	2.17e-05	0.00017	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—liver cancer	2.17e-05	0.00017	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—liver cancer	2.16e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAF1—liver cancer	2.14e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—liver cancer	2.14e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—liver cancer	2.14e-05	0.000167	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—liver cancer	2.09e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—liver cancer	2.09e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—liver cancer	2.08e-05	0.000163	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—liver cancer	2.08e-05	0.000163	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—liver cancer	2.07e-05	0.000162	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—liver cancer	2.04e-05	0.00016	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—liver cancer	2.04e-05	0.000159	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1B—liver cancer	2e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—liver cancer	2e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—liver cancer	1.98e-05	0.000155	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—liver cancer	1.98e-05	0.000155	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—liver cancer	1.98e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—liver cancer	1.97e-05	0.000154	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK14—liver cancer	1.97e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—liver cancer	1.96e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1B—liver cancer	1.96e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—liver cancer	1.96e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—liver cancer	1.95e-05	0.000153	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HMOX1—liver cancer	1.95e-05	0.000153	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—liver cancer	1.95e-05	0.000153	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—liver cancer	1.94e-05	0.000152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—liver cancer	1.93e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—liver cancer	1.92e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—liver cancer	1.92e-05	0.00015	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—liver cancer	1.91e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—liver cancer	1.91e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—liver cancer	1.91e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—liver cancer	1.91e-05	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—F2—liver cancer	1.91e-05	0.000149	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CTNNB1—liver cancer	1.89e-05	0.000148	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—liver cancer	1.88e-05	0.000147	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—liver cancer	1.87e-05	0.000147	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—liver cancer	1.87e-05	0.000146	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—liver cancer	1.86e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CTNNB1—liver cancer	1.85e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—liver cancer	1.85e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—liver cancer	1.83e-05	0.000143	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—liver cancer	1.82e-05	0.000143	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—liver cancer	1.82e-05	0.000143	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—liver cancer	1.82e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—liver cancer	1.82e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—liver cancer	1.81e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—liver cancer	1.81e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SERPINE1—liver cancer	1.81e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK8—liver cancer	1.8e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—liver cancer	1.8e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—liver cancer	1.8e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—liver cancer	1.79e-05	0.00014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK8—liver cancer	1.77e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—liver cancer	1.76e-05	0.000138	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A1—liver cancer	1.72e-05	0.000135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—liver cancer	1.72e-05	0.000134	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—liver cancer	1.67e-05	0.00013	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—liver cancer	1.66e-05	0.00013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—liver cancer	1.65e-05	0.000129	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—liver cancer	1.64e-05	0.000129	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—liver cancer	1.63e-05	0.000128	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAF1—liver cancer	1.63e-05	0.000128	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—liver cancer	1.62e-05	0.000126	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—liver cancer	1.61e-05	0.000126	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—liver cancer	1.6e-05	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—liver cancer	1.59e-05	0.000125	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—liver cancer	1.59e-05	0.000125	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	1.59e-05	0.000124	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SERPINE1—liver cancer	1.59e-05	0.000124	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARA—liver cancer	1.58e-05	0.000123	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—liver cancer	1.57e-05	0.000123	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—liver cancer	1.53e-05	0.00012	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFB1—liver cancer	1.53e-05	0.00012	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—liver cancer	1.52e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—liver cancer	1.5e-05	0.000118	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFB1—liver cancer	1.5e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1B—liver cancer	1.49e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—liver cancer	1.48e-05	0.000116	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—liver cancer	1.47e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—liver cancer	1.46e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—liver cancer	1.46e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—liver cancer	1.46e-05	0.000114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—liver cancer	1.44e-05	0.000113	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAF1—liver cancer	1.43e-05	0.000112	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—liver cancer	1.43e-05	0.000112	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—liver cancer	1.42e-05	0.000111	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—liver cancer	1.42e-05	0.000111	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CTNNB1—liver cancer	1.41e-05	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—liver cancer	1.4e-05	0.000109	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—liver cancer	1.4e-05	0.000109	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—liver cancer	1.39e-05	0.000109	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—liver cancer	1.38e-05	0.000108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—liver cancer	1.38e-05	0.000108	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—liver cancer	1.37e-05	0.000107	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—liver cancer	1.35e-05	0.000106	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK8—liver cancer	1.35e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—liver cancer	1.34e-05	0.000105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—liver cancer	1.33e-05	0.000105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1B—liver cancer	1.31e-05	0.000103	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—liver cancer	1.3e-05	0.000102	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—liver cancer	1.3e-05	0.000102	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—liver cancer	1.3e-05	0.000102	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—liver cancer	1.29e-05	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—liver cancer	1.28e-05	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—liver cancer	1.28e-05	0.0001	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—liver cancer	1.27e-05	9.98e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—liver cancer	1.26e-05	9.87e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—liver cancer	1.26e-05	9.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—liver cancer	1.25e-05	9.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—liver cancer	1.25e-05	9.78e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—liver cancer	1.24e-05	9.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CTNNB1—liver cancer	1.24e-05	9.71e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—liver cancer	1.23e-05	9.65e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—liver cancer	1.23e-05	9.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—liver cancer	1.22e-05	9.52e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—liver cancer	1.21e-05	9.48e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—liver cancer	1.2e-05	9.43e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—liver cancer	1.2e-05	9.43e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—liver cancer	1.19e-05	9.3e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK8—liver cancer	1.18e-05	9.25e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—liver cancer	1.18e-05	9.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—liver cancer	1.18e-05	9.23e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—liver cancer	1.17e-05	9.18e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—liver cancer	1.17e-05	9.14e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—liver cancer	1.15e-05	9.02e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—liver cancer	1.14e-05	8.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFB1—liver cancer	1.14e-05	8.93e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—liver cancer	1.13e-05	8.84e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—liver cancer	1.12e-05	8.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—liver cancer	1.09e-05	8.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—liver cancer	1.08e-05	8.46e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—liver cancer	1.06e-05	8.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—liver cancer	1.06e-05	8.27e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—liver cancer	1.04e-05	8.15e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—liver cancer	1.04e-05	8.1e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—liver cancer	1.03e-05	8.06e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—liver cancer	1e-05	7.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFB1—liver cancer	1e-05	7.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—liver cancer	9.71e-06	7.6e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—liver cancer	9.53e-06	7.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—liver cancer	9.39e-06	7.35e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—liver cancer	9.28e-06	7.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—liver cancer	8.98e-06	7.03e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—liver cancer	8.6e-06	6.73e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—liver cancer	8.52e-06	6.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—liver cancer	8.25e-06	6.46e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—liver cancer	7.93e-06	6.21e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—liver cancer	7.89e-06	6.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—liver cancer	7.55e-06	5.91e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—liver cancer	6.96e-06	5.45e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—liver cancer	6.31e-06	4.94e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—liver cancer	5.15e-06	4.04e-05	CbGpPWpGaD
